The Subcommittee on Health held a hearing entitled “Promoting the Development of Antibiotics and Ensuring Judicious Use in Humans” on Wednesday, June 9, 2010, in 2123 Rayburn House Office Building.  The hearing examined how we can best safeguard the effectiveness of antibiotics once they are on the market.  It also explored various ways to ensure adequate development of new, safe, and effective antibiotics.  The subcommittee expects to hold a subsequent hearing on the use of antibiotics in animals.

Witnesses

• Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, Food and Drug Administration
• Robin Robinson, Ph.D., Director, Biomedical Advanced Research and Development Authority, Department of Health and Human Services
• Brad Spellberg, M.D., F.I.D.S.A., Infectious Diseases Society of America, Associate Professor of Medicine, David Geffen School of Medicine at UCLA
• Sandra Fryhofer, M.D., Council on Science and Public Health, American Medical Association
• John S. Bradley, M.D., American Academy of Pediatrics, Chief, Division of Infectious Diseases, Department of Pediatrics, University of California, San Diego,  School of Medicine, Clinical Director, Division of Infectious Diseases, Rady Children’s Hospital
• Barry Eisenstein, M.D., F.A.C.P., F.I.D.S.A., Senior Vice President, Scientific Affairs, Cubist Pharmaceuticals
• Jeffrey Levi, Ph.D., Executive Director, Trust for America's Health

Documents

• Chairman Waxman's Opening Statement
• Briefing Memo
• Preliminary Transcript

Testimony

• Testimony of Janet Woodcock
• Testimony of Robin Robinson
• Testimony of Brad Spellberg
• Testimony of Sandra Fryhofer
• Testimony of John S. Bradley
• Testimony of Barry Eisenstein
• Testimony of Jeffrey Levi

Video

WMV
Download or Stream